Ion Beam Applications SA

Price Chart

Risk-Adjusted Performance

Also Listed On

Ion Beam Applications SA (IBAB) Price Performance

Ion Beam Applications SA (IBAB) trades on BR in EUR. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at EUR14.30, up 1.71% from the previous close.

Over the past year, IBAB has traded between a low of EUR9.55 and a high of EUR15.90. The stock has gained 49.7% over this period. It is currently 10.1% below its 52-week high.

Ion Beam Applications SA has a market capitalization of $425.01M, with a price-to-earnings ratio of 33.81 and a dividend yield of 1.75%.

About Ion Beam Applications SA

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN, a Belgian nuclear research center focusing on the development of Actinium-225, a radioactive isotope for the treatment of cancer. It also develops ConformalFLASH, a novel technique using the proton Bragg peak. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.